NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-326-2008-0-CA-04 Activators Of Human Pyruvate Kinase CA National Stage 2740148 Issued
NIDDK E-067-2010-0-AU-03 Inverse Agonists And Neutral Antagonists For the TSH Receptor AU National Stage 2011237421 Abandoned
NIDDK E-067-2010-0-CN-05 Inverse Agonists And Neutral Antagonists For the TSH Receptor CN National Stage 201180013235.9 Abandoned
NIDDK E-219-2011-2-US-02 CLINICAL DECISION MODEL US National Stage 13/083,184 8510245 Issued PDF
NIDDK E-067-2010-0-EP-06 Inverse Agonists And Neutral Antagonists For the TSH Receptor EP National Stage 11766807.9 Abandoned
NIDDK E-067-2010-0-PCT-02 Inverse Agonists And Neutral Antagonists For the TSH Receptor PCT PCT PCT/US2011/031752 Expired
NCI E-148-2011-0-US-01 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer US 61/473,409 Abandoned
CC E-090-2011-0-US-01 Thrombolytic Temperature-sensitive Liposomes US 61/473,665 Abandoned
NIAID E-150-2011-0-US-01 Ubiquitin Fusions For Improving The Efficacy Of Cytosolic Acting Targeted Toxins US 61/473,450 Abandoned
NINDS E-129-2011-0-US-01 BO-based Modulation Of Bl Excitation In MRI US 61/473,610 Abandoned
NICHD E-157-2011-0-US-01 Small Molecule (Derivatives Of Hydroxylamine) Therapeutic Compounds Targeting Thioesterase Deficiency Disorders And Methods of Using The Same US 61/473,692 Abandoned
NIDDK E-067-2010-0-CA-04 Inverse Agonists And Neutral Antagonists For the TSH Receptor CA National Stage 2789818 Abandoned
NIDDK E-067-2010-0-IN-07 Inverse Agonists And Neutral Antagonists For the TSH Receptor IN National Stage 2055/KOLNP/2012 Abandoned
NCI E-268-2012-0-DE-01 Niclosamide for the treatment of cancer metastasis DE ORD 11162875.6 Pending
NCI E-131-2011-0-US-01 Nitric Oxide Releasing Non-Steroidal Anti-Inflammatory Compounds And Uses Thereof In The Treatment And Prevention Of Diseases Or Disorders US 61/472,770 Abandoned
NCI E-281-2009-0-PCT-02 Diagnosis And Treatment of Cancer Through An NUAK2 Assessment and Modulation PCT PCT PCT/US2011/031483 Abandoned
NIA E-251-1997-0-JP-29 DIFFERENTIATION OF NON-INSULIN PRODUCING CELLS INTO INSULIN PRODUCING CELLS BY GLP-1 OR EXENDIN-4 AND USES THEREOF JP DIV 2011-083828 Abandoned
NCI E-200-2011-2-US-01 METHODS OF TREATING LYMPHOCYTIC LEUKEMIA USING INHIBITORS OF BRUTON'S TYROSINE KINASE US 61/472,138 Abandoned
NCI E-010-2008-0-US-03 METHODS AND COMPOSITIONS FOR PROTEIN DELIVERY US National Stage 13/122,513 9296790 Issued PDF
NCI E-272-1998-0-US-05 TUMOR SUPPRESSOR GENE p33ING2 US DIV 13/079,743 8206937 Abandoned PDF
NCI E-149-2011-0-US-01 Design, Generation, And Characterization Of A Monoclonal Antibody Against The NADPH Oxidase 5 (NOX5) Protein US 61/471,596 Abandoned
NIAID E-005-2009-1-US-02 Flavivirus-based System For Production Of Hepatitis C Virus (HCV) US National Stage 13/122,154 9052321 Issued PDF
NCI E-116-2001-0-HK-38 Formulation of Boronic Acid Compounds HK EP 11103293.5 Expired
NIAID E-019-2007-2-US-10 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS US CON 13/077,488 8580277 Abandoned PDF
NICHD E-042-2013-0-PCT-02 Injectable Dendrimer Hydrogel Nanoparticles PCT PCT PCT/US2011/030648 Expired
NICHD E-042-2013-0-EP-04 Injectable Dendrimer Hydrogel Nanoparticles EP National Stage 11763407.1 Abandoned
NCI E-181-2006-0-US-09 MicroRNA-based Methods and Compositions for the Diagnosis, Prognosis, And Treatment of Lung Cancer using Mir-17-3P US DIV 13/075,828 8377637 Abandoned PDF
NCI E-181-2006-0-US-10 MicroRNA-Based Methods And Compositions For the Diagnosis, Prognosis, and Treatment of Lung Cancer Using MIR-21 US DIV 13/075,820 8361710 Abandoned PDF
NHGRI E-094-2010-0-PCT-02 Adenosine Receptor Agonists For The Treament And Prevention Of Vascular Or Joint Capsule Calcification Disorders PCT PCT PCT/US2011/030493 Expired
NICHD E-339-2008-2-US-05 Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia US National Stage 13/121,574 8444996 Abandoned PDF
NINDS E-113-2011-0-US-01 Wirelessly Powered MRI Signals Amplification System and Method US 61/468,911 Abandoned
NCI E-283-2008-0-US-06 Method For Detection Of Cancer Based On Spatial Genome Organization US National Stage 13/062,247 9617599 Abandoned PDF
NIAID E-341-2008-0-US-03 DNA Prime/Inactivated Vaccine Boost Immunization To Influenza Virus US National Stage 13/121,004 Abandoned
NCI E-314-2008-0-US-03 Inflammatory Genes And MicroRNA21 As Biomarkers For Colon Cancer Prognosis US National Stage 13/121,020 Abandoned
NCI E-051-2010-0-PCT-02 Human Polyomavirus 6 (HPyV6) And Human Polyomavirus (HPyV7) PCT PCT PCT/US2011/029903 Abandoned
NCI E-047-2011-0-US-01 High-affinity Fully Functional Soluble Single-domain Human CD4 US 61/467,570 Abandoned
NIA E-084-2011-0-US-01 Compositions And Methods For Enhancing The Pluripotentcy of Stem Cells US 61/466,667 Abandoned
NCI E-261-2005-2-US-03 Method For Diagnosing and Monitoring the Progression of Cancer by Measuring Soluble c-Met Ectodomain US DIV 13/053,560 8304199 Issued PDF
NCI E-114-2011-0-US-01 Methods of Growing Tumor Infiltrating Lymphocytes (TIL) in Gas-Permeable Containers US 61/466,200 Abandoned
NCI E-285-2006-2-US-05 Differential Gene Expression in Physiological And Pathological Angiogenesis US CON 13/052,878 8440411 Issued PDF
NCI E-019-2010-2-EP-02 Nitroxyl (HNO) Releasing Compounds And Uses Thereof In Treating Diseases EP National Stage 11711417.3 Abandoned
NIDDK E-285-2008-0-US-07 A3 Adenosine Receptor Antagonists And Partial Agonists US National Stage 13/056,997 8796291 Abandoned PDF
NCI E-019-2010-2-PCT-01 Nitroxyl (HNO) Releasing Compounds And Uses Thereof In Treating Diseases PCT PCT COMB PCT/US2011/029072 Expired
NIDDK E-125-2010-0-PCT-02 Nicotinic Acetylcholine Receptor Agonists PCT PCT PCT/US2011/028989 Expired
NHGRI E-060-2011-0-US-01 Methods for Treating Leukemia And Disorders Mediated By CBFB AND RUNX1 Proteins US 61/453,863 Abandoned
NCI E-056-2011-0-US-01 Yeast-Brachyury Immunotherapeutic Compositions US 61/453,656 Abandoned
NINDS E-251-2005-2-EP-05 SYSTEMS AND METHODS FOR RECOVERY FROM MOTOR CONTROL VIA STIMULATION TO A SUBSTITUTED SITE TO AN AFFECTED AREA EP National Stage 09815119.4 Issued
NINDS E-251-2005-2-FR-11 SYSTEMS AND METHODS FOR RECOVERY FROM MOTOR CONTROL VIA STIMULATION TO A SUBSTITUTED SITE TO AN AFFECTED AREA FR EP 09815119.4 Issued
NINDS E-251-2005-2-DE-09 SYSTEMS AND METHODS FOR RECOVERY FROM MOTOR CONTROL VIA STIMULATION TO A SUBSTITUTED SITE TO AN AFFECTED AREA DE EP 09815119.4 Issued
NINDS E-251-2005-2-GB-12 SYSTEMS AND METHODS FOR RECOVERY FROM MOTOR CONTROL VIA STIMULATION TO A SUBSTITUTED SITE TO AN AFFECTED AREA GB EP 09815119.4 Issued